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ABSTRACT
Corona virus disease 2019 (COVID-19) is a fast spreading pandemic which has started in China, then spread worldwide with high infectious rate and significant minor mortality. The natural
history of COVID19 is not yet fully understood as it mainly affects and spreads through the respiratory system but it may affect other systems. Furthermore, it is an overwhelming disease to the
health system which mandates building new hospitals such as Nightingale in London and also emptying several tertiary hospitals in order to cope with the huge demands on the health system globally. Therefore, urology as a specialty become affected where hundreds of elective surgeries to be
delayed. Thus, we think that we should have a regional guidance regarding how to deal with urological surgeries in the Middle East based on current international available data so we can provide
safety to healthcare workers (HCW) but without scarifying patient’s health and priority. We have
postulated an algorithm and set recommendations which can serve as guidance during COVID 19
pandemic in the Middle East.
Keywords: Covid 19, Urological Surgery, Kidney, Bladder And Prostate Cancer, Middle East
Urology.
INTRODUCTION
The World Health Organization (WHO)
declared the epidemic of Corona virus disease 2019 (COVID-19) as a pandemic on
March 12th 2020. Currently, it has spread almost to every continent of the world where it
has started in Wuhan, China [1]. It is mainly
a respiratory disease characterized by sever
Acute Respiratory Syndrome (ARDS) which
leads to significant morbidity and noticeable
mortality [2]. Nevertheless, morbidity and
mortality related to COVID-19 is not the only
concern facing the health system as hospitals
capacity, elective surgeries cancelation and
Healthcare workers (HCW) safety are paramount [3]. For instance, the American college of surgeons recommends cancelation of
all elective surgeries [4].

To a greater extent, Urological procedures are elective as only a handful of procedures that need immediate to urgent intervention. However, elective urological surgery is
a vague and broad term which may lead to
devastating outcome if used inappropriately.
Therefore, a triage system and set of recommendations should be established in each
institution in cooperation with higher management level in order to achieve safe delayed urological procedures as well as to
keep up with international emergency response to COVID-19 [5].
Urologist can help fight this pandemic
not only by actively participating in treating
COVID-19 patients but also by triaging and
delaying some surgeries which will lead to a
decrease in the demand for ventilators, personal protective equipment, and other critical
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hospital and human resources. However, this
should be counterbalanced by the possible
dangerous outcome of delaying surgeries especially for malignant urological procedures.
Several Urological societies such as European association of urology (EAU) published their guidance on the managing urological conditions during the Covid-19 pandemic[6]. However, we don’t have local or
regional guidance to deal with urological
surgery as for example Palestinian national
COVID-19 management protocol deals with
just COVID-19 cases regarding evaluation
and management [7]. While this guidance is
likely to change and evolve as we move
deeper into the pandemic, there are similarities that could be applied to urological surgery across the globe. However, with the
varying models and different operational levels of readiness between health systems,
some of these recommendations can be tailored to be best applied to most healthcare
systems in the Middle East. The Middle East
has a different cohort of patients regarding
age, co-morbidities and prevalence of urological problems. Furthermore, hospitals are less
equipped, personal protective equipment are
limited but currently COVID-19 appears not

to have the same pattern of spread compared
to western countries and South East Asian
countries as well. Therefore, we have
searched and summarized the literature in
order to have a regional guidance to deal with
common urological procedures during the
pandemic in order to be prepared for increasing in COVID-19 patients’ numbers and consequently the demands on health system.
The main purpose of this article is to establish preliminary recommendations and
algorithm to deal with urological procedures
during COVID 19 as the disease has not hit
the peak yet. We have reviewed all current
available date that links COVID-19 to urological surgeries and summarized the evidence, in addition to virtual round table discussion between authors which was done
online using social media and skype due to
the current quarantine situation. Members of
the expert panel are listed in Table 1.
This is an early call so it can be adopted
as a regional reference and may provide a
starting point for discussions to continue and
develop further at local level. Appropriate
urological procedures during COVID-19
pandemic are shown in Figure 1.

Table (1): Group of the expert panel.
Name
F Abushamma
A Jaradat
R Alazab

S AL Demour

S Albuheissi
A Mustafa
A. Alzarooni

A Alansari
K Al-Rumaihi

Position
AP and CUS
Program director
AP and CUS

Affiliation
Department of surgery, An-Najah National University,
Nablus, Palestine
Department of surgery, An-Najah National University,
Nablus, Palestine
AsP and CUS
Department of urology, Jordan University of science
President JAUS
and Technology, Irbid, Jordan
Jordanian Association of urological surgeons (JAUS)
AP and CUS
Department of special surgery, Division of Urology,
school of medicine, The University of Jordan, Amman,
Jordan
Clinical lead and Bristol Urological Institute, North Bristol NHS Trust,
CUS
Bristol, United Kingdom.
SCF
Department of respiratory, University hospital Birmingham NHS trust, Birmingham, United Kingdom.
CUS
Department of urology, Sheikh Khalifa General HospiHead of urology tal, United Arab Emirates
dep
President of EUS
Emirates Urological society
CUS
Surgical Department, Hamad General Hospital, Hamad
CMO
Medical Corporation, Doha, Qatar
CUS
Surgical Department, Hamad General Hospital, Hamad
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Name

O Aboumarzouk

Position
Director of Urology
Honorary clinical
senior lecturer
CUS

Affiliation
Medical Corporation, Doha, Qatar
University of Glasgow, Glasgow, Scotland, United
Kingdom.
Surgical Department, Hamad General Hospital, Hamad
Medical Corporation, Doha, Qatar

AsP: Associate professor, AP: Assistant Professor, CUS: consultant urological surgeon, SCF: Senior clinical
fellow, CMO: chief medical officer.

Urology malignancy surgery
Urological malignancy is a worldwide
prevalent disease associated with mortality
and morbidity. The incidence increases every
year which is directly related to the expansion of elderly people category mainly in the
developed countries. In 2013, 2.1 million
kidney, bladder, and prostate cancer cases
occurred worldwide with 1.6-fold increase in
mortality rate in comparison to 1990 [8].
There is strong evidence that COVID-19
mortality is higher in elderly people especially if concomitant co-morbidities are present
[9]. Thus, Urological malignancy cohort of
patients are at higher risk of morbidity and
mortality especially if it is associated with
delays in their planned surgery.
Renal Cell Carcinoma (RCC)
T1 RCC
The standard treatment of RCC less than
7cm is partial nephrectomy regardless to the
type of surgery[10]. Furthermore, the length
of stay is between (1-2 days) for robotic and
laparoscopic procedures while it is (2-4 days)
for open surgery [11]. This will lead to increase demands on beds, ventilators and also
exhaustion of HCP during the Pandemic
while the risk of progression and metastasis
is not significant over a short period of time.
For instance, the linear growth rate for RCC
less than 4 cm ranges between 0.1-0.4 cm/
year with mortality rate less than 1% [12].
Recommendation: Delay surgery for 3
months, then perform restaging and proceed
according to stage.
T2 RCC

age, morbidity, symptoms, and tumour
growth rate.
T3+ RCC
This category of localized RCC is the
highest risk for progression especially if there
is evidence of vein thrombus. The progression may occur rapidly and lead to more
complicated surgery and adversely affect
survival and morbidity [13, 14].
Recommendation: Nephrectomy for all
patients (Open or minimally invasive)
Prostate cancer
Localized prostate cancer management is
continuously changing over time and treatment options include active monitoring, radical prostatectomy, and radiotherapy. However, recent evidence shows at a median of 10
years, prostate-cancer–specific mortality was
low irrespective of the treatment assigned,
with no significant difference among treatments [15]. Furthermore, delay of treatment
up to 12 months, even for high risk disease,
may not alter operative outcomes and cancer
specific mortality [16]. Therefore, we think
that surgery for prostate cancer can be safely
delayed in the Middle East for 3 months.
Alternatively, radiotherapy can be considered
for high risk localized prostate cancer and
locally advance prostate cancer especially in
relatively young patients.
Recommendation
1.

Radical prostatectomy (RP) surgery can
be delayed safely up to 3 months for localized prostate cancer.

2.

Consider Radiotherapy (RXT) for locally
advanced non metastatic prostate cancer

Recommendation: Surgery for these tumours should be considered for delay based
upon patient specific considerations, such as
 ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــPalestinian Medical and Pharmaceutical Journal (PMPJ). 2020; 5(2): 133-139

136  " ـــــــــــــــــــ ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــRecommendations and algorithm to deal with urological surgeries in ……"

Bladder cancer
Non- muscle invasive bladder cancer
(NMIBC):
NMIBC is associated with slow progression rate mainly if it is Ta or Low grade. On
the other hand progression rate for T1 high
grade tumour is up to 65% and disease specific survival is 69% at 15 years follow up
[17]. Furthermore, first presentation T1 or
high grade NMIBC is associated with significant understating rate up to 50% [18]. Therefore, known case Low grade or pTa NMIBC
can be safely delayed up to 3months but pT1
or high grade tumours should not be delayed.
Recommendation
1.

Ta or Low grade: Delay up to 3 months
is safe.

2.

T1 or high grade NMIBC: Prompt
TURBT is recommended.

Muscle invasive bladder cancer (MIBC)
Untreated patients with MIBC are at
higher risk of morbidity and mortality related
to disease progression. Overall, 5 years OS
rate for untreated patients is 5% and cumulative incidence of CSM is 86%. [19]. Furthermore, delaying cystectomy for MIBC by
90 days decreases overall and progression
free survival [20]. Thus, cystectomy is still
recommended as standard treatment and
should not postponed.
Recommendation: Cystectomy for
MIBC with hold on neoadjuvant chemotherapy.
Upper tract urothelial carcinoma
Recommendation
1.

Can be delayed up to 3 months [21].

2.

cT1 + or high-grade disease on cytology,
it is recommended to proceed with
Nephroureterectomy

Testicular cancer
Testicular cancer is a rare malignancy
among Arab population with scanty data
available. It affects young age group (20-35
years old) and mainly it is Seminoma [22].
Furthermore, inguinal orchiectomy is a day
case procedure which associated with low
complications rate. There is no much data

regarding the effect of delayed orchiectomy
on clinical stage, morbidity and mortality,
however, it is evident that diagnostic delay in
testicular cancer is significantly correlated
with stage and survival in Nonseminomatous germ cell tumors (NSGCT)
[23]. Therefore, inguinal orchiectomy should
be done promptly once diagnosis is established.
Retroperitoneal lymph node dissection
(RPLND) should be discussed through regional multidisciplinary team (MDT). with
oncologist and radiologist to consider other
treatment options such as chemotherapy, radiation and observation if clinically feasible.
Recommendation
1.

Inguinal orchiectomy should be performed for US-proven suspected neoplasm within 1 week

2.

RPLND should be discussed through
MDT to balance available treatment options

Penile cancer
Penile cancer is considered a rare malignancy worldwide and in Arab countries, it
has very low incidence rate with scanty data
available [24]. Therefore, it is not discussed
in this article.
Urology non-malignancy surgery
It is difficult to cover all non- malignant
urology topics in this article but this article
describes urological emergency surgery
which should not be delayed as it may cause
significant harm.
Stones
Obstructed and infected urinary tract is
associated with significant morbidity and
mortality if left untreated. Drainage of the
system by either JJ stent or nephrostomy has
to be done urgently without delay [25].
Furthermore, bedside ureteral stent
placement is well tolerated, safe and efficacious using local anaesthesia especially in
females [26]. Thus, it can be safely done as
outpatient or day case procedure to decompress upper urinary tract mainly in cases with
Acute Kidney injury (AKI) or intractable
pain.
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Recommendation

1. Offer ureteric stent or nephrostomy urgently for obstructed and infected upper
urinary tract.

low shows most common urological emergency which should not be delayed and managed promptly [27].
1.

Paraphimosis: Outpatient procedure.

2.

Penile fracture: Day case procedure
should be arranged as surgical outcome
is better regarding long term erection and
curvature [28].

3.

Priapism: Shunting procedures should
not be delayed if clinically indicated to
maximize outcomes for patients and decrease complication rate [29].

2. Delay the definitive procedure such as
BPH surgery and stricture surgery.

4.

Fournier gangrene: Urgent assessment
and intervention.

Urological Emergencies

5.

Testicular torsion: Urgent intervention

Urological Emergencies can affect any
part of the urinary tract. However, urology as
a specialty has few urological emergencies
which needs urgent intervention. The list be-

Urological trauma should be treated according to the standard protocol but tailored
to meet local guidelines.

2. Consider local anaesthetic day case stent
insertion if tolerated.
Urine retention secondary to bladder out
let obstruction
Recommendation
1. Drain the bladder by urethral catheter or
suprapubic catheter (SPC).

Figure (1): Algorithm for appropriate urological procedures during COVID-19 pandemic done by
Abushamma et al using https://www.diagrameditor.com/. HG: high grade, UTUC: upper tract
urothelial carcinoma, LA: Local anesthesia, SPC: suprapupic catheter, NUx: Nephroureterectomy.
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CONCLUSIONS
COVID 19 pandemic is affecting every
aspect in health system and imply huge demands on hospitals, healthcare workers and
equipment. Thus, effort should put in place to
coordinate work load and help fighting this
disease.
These recommendations and algorithm
present preliminary expert opinion from this
group based on best available data. We hope
that this article will help to create an evidence-based work strategy during this pandemic and provide an initial point for discussions to continue at local level. There should
be a high level of cooperation between medical teams and management to get work organized across different departments. Therefore, decrease the negative impact of
COVID-19 on patients, hospitals and HCW.
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